[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Germany Respiratory Diseases 2017-2022: Supplier Shares, Market Segment Forecasts, Competitive Strategies--Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Technology and Instrumentation Review, Emerging Opportunities

January 2018 | 283 pages | ID: GE145364595EN
Venture Planning Group

US$ 1,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
About This Report

This new 283-page report from VPGMarketResearch.com presents detailed analysis of the German Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market share and sales forecasts, the report: - Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies; - Reviews features and operating characteristics of major analyzers used for microbiology testing; - Profiles key suppliers and potential market entrants developing innovative technologies and products; and - Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products. In addition to primary sources of information, a comprehensive review ofthe most recent technical and business publications, manufacturer productand financial literature, as well as VPGMarketResearch’s proprietary data files was conducted. Contains 283 pages and 23 tables


More Publications